PITTSBURGH--(BUSINESS WIRE)--ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, today announced the limited launch of its next generation Hemolung CR4 Controller. The Hemolung CR4 Controller is part of the Hemolung Respiratory Assist System (RAS) which provides minimally invasive extracorporeal CO2 removal as an alternative or supplement to mechanical ventilation for patients suffering from acute respiratory failure.
Help employers find you! Check out all the jobs and post your resume.
